ECI
DXCM icon

EFG Capital International’s DexCom DXCM Stock Holding History

EFG Capital International’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$448K Buy
+3,483
New +$421K 0.1% 111

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

EFG Capital International's DXCM Position: Q2 2023 in Review

EFG Capital International opened a new position in DexCom (DXCM) in Q2 2023: 3,483 shares worth $448K. The stake represents 0.1% of the portfolio and ranks #111 among its holdings.

954 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

  • EFG Capital International held 3,483 shares of DexCom worth $448K as of Q2 2023.
  • DexCom was a new EFG Capital International position in Q2 2023.
  • DexCom made up 0.1% of EFG Capital International's portfolio in Q2 2023, its #111 holding.
  • 954 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on EFG Capital International's 13F filing for Q2 2023, filed 2 Aug 2023.